AXL and neoplasm: Expression of AXL in the cell cytoplasm of pre-EGFR-TKI-treated tumor samples was evaluated using immunohistochemistry (IHC) staining and scored as high (3+), intermediate (2+), low (1+), and no (0) expression of AXL (Supplementary Figure 7A).